SI-BONE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
SI-BONE, INC. (SIBN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 2.77 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-04
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 1.10K shares, a 92.29% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 1.67K shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 16.88K shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 1.10K shares, a 60.45% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 32.24K shares, a 728.29% increase from fiscal 2024.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 3.89K shares, a 75.68% decline from fiscal 2023.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 16.01K shares, a 37.48% decline from fiscal 2022.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 25.60K shares, a 5.42% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 2.77K shares 10-Q · filed 2026-08-04 | 19.64K shares derived: sum of 3 quarters · filed 2026-08-04 | 20.74K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 1.67K shares 10-Q · filed 2026-05-11 | 18.54K shares derived: sum of 2 quarters · filed 2026-05-11 | 19.64K shares derived: sum of 3 quarters · filed 2026-05-11 | 33.90K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 16.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 17.98K shares derived: sum of 2 quarters · filed 2026-02-24 | 32.24K shares derived: sum of 3 quarters · filed 2026-02-24 | 32.24K shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 1.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 15.36K shares derived: sum of 2 quarters · filed 2025-11-10 | 15.36K shares 10-Q · filed 2025-11-10 | 15.36K shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 14.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 14.26K shares 10-Q · filed 2025-08-05 | 14.26K shares derived: sum of 3 quarters · filed 2025-08-05 | 17.04K shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-06 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-06 | 2.78K shares derived: sum of 3 quarters · filed 2025-05-06 | 3.89K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 2.78K shares derived: sum of 2 quarters · filed 2025-02-25 | 3.89K shares derived: sum of 3 quarters · filed 2025-02-25 | 3.89K shares 10-K · filed 2025-02-25 |
| 2024-09-30 | 2.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 3.89K shares derived: sum of 2 quarters · filed 2024-11-12 | 3.89K shares 10-Q · filed 2024-11-12 | 3.89K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 1.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 1.11K shares 10-Q · filed 2024-08-06 | 1.11K shares derived: sum of 3 quarters · filed 2024-08-06 | 1.11K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-07 | 4.00 shares derived: sum of 3 quarters · filed 2024-05-07 | 722.00 shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 4.00 shares derived: sum of 2 quarters · filed 2024-02-27 | 722.00 shares derived: sum of 3 quarters · filed 2024-02-27 | 16.01K shares 10-K · filed 2024-02-27 |
| 2023-09-30 | 4.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 722.00 shares derived: sum of 2 quarters · filed 2023-11-07 | 16.01K shares 10-Q · filed 2023-11-07 | 17.37K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | 718.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 16.00K shares 10-Q · filed 2023-08-08 | 17.37K shares derived: sum of 3 quarters · filed 2024-02-27 | 27.37K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | 15.28K shares 10-Q · filed 2023-05-02 | 16.65K shares derived: sum of 2 quarters · filed 2024-02-27 | 26.66K shares derived: sum of 3 quarters · filed 2024-02-27 | 29.53K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | 1.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 11.37K shares derived: sum of 2 quarters · filed 2024-02-27 | 14.25K shares derived: sum of 3 quarters · filed 2024-02-27 | 25.60K shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 10.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 12.88K shares derived: sum of 2 quarters · filed 2022-11-08 | 24.24K shares 10-Q · filed 2022-11-08 | 26.09K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 2.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 14.23K shares 10-Q · filed 2022-08-09 | 16.08K shares derived: sum of 3 quarters · filed 2023-03-02 | 18.13K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 11.36K shares 10-Q · filed 2022-05-10 | 13.21K shares derived: sum of 2 quarters · filed 2023-03-02 | 15.25K shares derived: sum of 3 quarters · filed 2023-03-02 | 38.37K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 1.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 3.90K shares derived: sum of 2 quarters · filed 2023-03-02 | 27.02K shares derived: sum of 3 quarters · filed 2023-03-02 | 27.07K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 2.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 25.17K shares derived: sum of 2 quarters · filed 2021-11-09 | 25.22K shares 10-Q · filed 2021-11-09 | 27.24K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | 23.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 23.17K shares 10-Q · filed 2021-08-04 | 25.20K shares derived: sum of 3 quarters · filed 2022-03-01 | 36.14K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | 50.00 shares 10-Q · filed 2021-05-04 | 2.08K shares derived: sum of 2 quarters · filed 2022-03-01 | 13.02K shares derived: sum of 3 quarters · filed 2022-03-01 | 14.28K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | 2.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 12.97K shares derived: sum of 2 quarters · filed 2022-03-01 | 14.23K shares derived: sum of 3 quarters · filed 2022-03-01 | 15.55K shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 10.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | 12.21K shares derived: sum of 2 quarters · filed 2020-11-03 | 13.52K shares 10-Q · filed 2020-11-03 | 33.31K shares derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-06-30 | 1.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 2.58K shares 10-Q · filed 2020-08-04 | 22.37K shares derived: sum of 3 quarters · filed 2021-03-10 | |
| 2020-03-31 | 1.32K shares 10-Q · filed 2020-05-05 | 21.11K shares derived: sum of 2 quarters · filed 2021-03-10 | ||
| 2019-12-31 | 19.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | 116.29K shares 10-K · filed 2021-03-10 | ||
| 2019-09-30 | 96.50K shares 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | 65.69K shares 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |